Literature DB >> 6823332

A severe combined immunodeficiency mutation in the mouse.

G C Bosma, R P Custer, M J Bosma.   

Abstract

The most debilitating human lymphoid deficiency disease, known as severe combined immunodeficiency (SCID), impairs the differentiation of both T and B lymphocytes. Affected infants are highly susceptible to recurring infections of viruses, fungi and bacteria and invariably die within 2 yr of birth. Inheritance of this congenital syndrome may show X-linked or autosomal recessive control. To date autosomal recessive inheritance of SCID has been observed in Arabian foals which represent the only known animal model of this disease syndrome but here we report an autosomal recessive mutation in mice that severely impairs lymphopoiesis. Mice homozygous for this mutation have few if any lymphocytes; consequently they are hypogammaglobulinaemic and deficient for immune functions mediated by T and B lymphocytes. These mice, therefore, represent a new model for investigating how lymphoid differentiation may be impaired in the disease state and regulated in the normal state.

Entities:  

Mesh:

Year:  1983        PMID: 6823332     DOI: 10.1038/301527a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  629 in total

Review 1.  Primary T-lymphocyte immunodeficiencies.

Authors:  A Fischer
Journal:  Clin Rev Allergy Immunol       Date:  2001-02       Impact factor: 8.667

2.  Age-dependent increase of peritoneal B-1b B cells in SCID mice.

Authors:  Kirk S Hinkley; Rod J Chiasson; Tracey K Prior; James E Riggs
Journal:  Immunology       Date:  2002-02       Impact factor: 7.397

Review 3.  Are natural killer cells the key to treating Epstein-Barr virus-associated lymphoproliferative disorders?

Authors:  M J Robertson
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

4.  Activation of V(D)J recombination induces the formation of interlocus joints and hybrid joints in scid pre-B-cell lines.

Authors:  S Lew; D Franco; Y Chang
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

5.  Activities of hexadecylphosphocholine (miltefosine), AmBisome, and sodium stibogluconate (Pentostam) against Leishmania donovani in immunodeficient scid mice.

Authors:  P Escobar; V Yardley; S L Croft
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

Review 6.  Insights into T-cell development from studies using transgenic and knockout mice.

Authors:  M A Basson; R Zamoyska
Journal:  Mol Biotechnol       Date:  2001-05       Impact factor: 2.695

7.  Experimental infection of severe combined immunodeficient beige mice with Mycobacterium paratuberculosis of bovine origin.

Authors:  G K Mutwiri; D G Butler; S Rosendal; J Yager
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

8.  A DNA-PKcs mutation in a radiosensitive T-B- SCID patient inhibits Artemis activation and nonhomologous end-joining.

Authors:  Mirjam van der Burg; Hanna Ijspeert; Nicole S Verkaik; Tuba Turul; Wouter W Wiegant; Keiko Morotomi-Yano; Pierre-Olivier Mari; Ilhan Tezcan; David J Chen; Malgorzata Z Zdzienicka; Jacques J M van Dongen; Dik C van Gent
Journal:  J Clin Invest       Date:  2008-12-15       Impact factor: 14.808

9.  Continuous nasal administration of antigen is critical to maintain tolerance in adoptively transferred autoimmune arthritis in SCID mice.

Authors:  T Bárdos; M Czipri; C Vermes; J Zhang; K Mikecz; T T Glant
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

10.  Failure of SCID mice to generate an oral tolerogen after a feed of ovalbumin: a role for a functioning gut-associated lymphoid system.

Authors:  E Furrie; M W Turner; S Strobel
Journal:  Immunology       Date:  1994-12       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.